# Federal Reserve

Type: organization

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/federal-reserve-organization
Canonical HTML page: https://getbiobrief.com/entity/federal-reserve-organization

## Timeline

- **2026-03-20**: Pharma and Corporate Shifts — Strides Pharma announces ibuprofen recall; Compass drops Zillow lawsuit to focus on operations.
- **2026-03-19**: Global Contagion — Asian and European markets sell off; Planet Labs reports widening Q4 losses.
- **2026-03-18**: Legal and Macro Shock — Arizona files criminal charges against Kalshi; Jerome Powell issues hawkish inflation warnings.

## Recent coverage (3 stories)

### Arizona Files Criminal Charges Against Kalshi Amid Broad Market Sell-Off
2026-03-21 00:11:38 · Sentiment: Bearish · Impact: 8/10 · Sources: 15

Arizona has initiated criminal proceedings against prediction market Kalshi for alleged illegal betting, occurring simultaneously with a global market downturn triggered by Federal Reserve inflation warnings. In the pharmaceutical sector, Strides Pharma has issued a recall for children's ibuprofen, highlighting operational risks during a period of heightened regulatory and economic pressure.
Full story: https://getbiobrief.com/story/arizona-charges-kalshi-market-volatility-pharma

### Morgan Stanley Warns of 2026 Political Risks to Pharma and Biotech
2026-03-09 00:26:45 · Sentiment: Neutral · Impact: 8/10 · Sources: 2

A new Morgan Stanley report identifies 'affordability politics' as a primary risk for the pharmaceutical sector ahead of the 2026 midterm elections. The firm warns that targeted legislative measures to lower prescription drug costs could create significant pricing pressure on high-margin brand-name drugs.
Full story: https://getbiobrief.com/story/morgan-stanley-political-risks-pharma-2026

### AI Disruption Fears and MedTech Earnings Drive Healthcare Volatility
2026-02-18 01:00:17 · Sentiment: Bearish · Impact: 7/10 · Sources: 28

US equities faced a volatile session as investors reassessed the 'dark side' of AI disruption, dragging the Nasdaq into its fifth consecutive week of losses. Within the healthcare sector, attention is fixed on Medtronic's earnings and Masimo's performance as the industry grapples with shifting valuations.
Full story: https://getbiobrief.com/story/ai-disruption-medtech-earnings-market-volatility

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.